Diferansiye tiroid kanserlerinde prognostik faktörlerin cinsiyetler arasında karşılaştırmalı olarak retrospektif değerlendirilmesi

Amaç: Diferansiye tiroid kanserleri en sık rastlanan endokrin kanser olmakla birlikte son yıllarda sıklığı da giderek artmaktadır. Diferansiye tiroid kanserleri kadınlarda daha sık görülmekle beraber erkeklerde daha progresif seyir göstermektedir. Çalışmamızda İzmir Atatürk Eğitim ve Araştırma Hastanesi Endokrinoloji Kliniğinde diferansiye tiroid kanseri tanısı ile takip edilen hastalarda prognostik faktörlerin cinsiyetler arasında karşılaştırılması amaçlandı. Gereç ve Yöntem: Kliniğimize cerrahi sonrası diferansiye tiroid kanseri tanısı ile yönlendirilen hastalar geriye dönük olarak değerlendirildi. Klinik verileri tam olan 458 hasta çalışmamıza dahil edildi. Bulgular: Hastalarımızın 68'i (%14.8) erkek, 390'ı (%85.2) kadın olup tanı anındaki yaş ortalamaları 49.8 ±12.6 idi. Erkek ve kadın hastaların tanı anındaki yaş ortalamaları sırasıyla 54.6 (±13.6) ve 48.9 (±12.2) idi (p

A retrospective gender-comparative evaluation of the prognostic factors in differentiated thyroid cancers

Aim: Differentiated thyroid cancers are the most common endocrine cancer types among all. Differentiated thyroid cancers are more common with women, but the prognosis tends to be poorer in men. This study aims to compare prognostic factors between genders in the patients who are being treated with a differentiated thyroid cancer diagnosis in İzmir Atatürk Research and Training Hospital Endocrinology Department. Materials and Methods: The 458 patients who were treated with a diagnosis of differentiated thyroid carcinoma in our department were included in this retrospective study. Results: Sixty-eight (14.8%) of the patients were male and 390 (85.2%) of the patients were female. The mean age of the patients included in the study was 49.8 (±12.6) at the time of diagnosis. The mean age of the male and female patients were 54.6 (±13.6) and 48.9 (±12.2), respectively (p<0.05). The medium value of the tumor size of the patients was 11.5 mm, whereas 13.5 mm in men and 11.0 mm in women (p<0.05). Lymph node metastasis was detected in 40 (18.6%) patients. In patients with lymph node metastasis, 11 (16.1%) were male. The rate of lymph node metastasis were higher in men (p<0.05). In this study, the mean age and the tumor size at the time of diagnosis and the percentage of the lymph node metastasis in men was found significantly higher than that of women. Conclusion: Differentiated thyroid cancers tend to have poor prognosis in men and this may be due to being diagnosed on an advanced age and with a larger size.

___

  • 1. Wells SA. Cancer of the Endocrine System. In Devita VT, Hellman S, Rosenberg SA (eds). Cancer: Principles and Practice of Oncology. 8th Ed., Philadelphia Lippincott Williams&Wilkins, 2008:1655-82.
  • 2. Greene FL, Balch CM, Fleming ID, et al. AJCC cancer staging handbook: TNM classification of malignant tumors: Springer Science & Business Media; 2002.
  • 3. Shaha AR. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope. 2004;114(3):393-402.
  • 4. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154(6):787-803.
  • 5. Morganti S, Ceda GP, Saccani M, Milli B, Ugolotti D, Prampolini R, et al. Thyroid disease in the elderly: Sex-related differences in clinical expression. J Endocrinol Invest 2005;28(11 Suppl Proceedings):101-4.
  • 6. Shah JP, Loree TR, Dharker D, Strong EW, Begg C, Vlamis V. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1992;164(6):658-61.
  • 7. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53.856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998;15;83(12):2638-48.
  • 8. Dean DS, Hay ID. Prognostic indicators in differentiated thyroid carcinoma. Cancer Control 2000;7(3):229-39.
  • 9. Nagataki S, Nystrom E. Epidemiology and primary prevention of thyroid cancer. Thyroid 2002;12(10):889-96.
  • 10. Jukkola A, Bloigu R, Ebeling T, Salmela P, Blanco G. Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr Relat Cancer 2004;11(3):571-9.
  • 11. Zeng Q, Chen G, Vlantis A, Tse G, van Hasselt C. The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas. J Pathol 2008;214(4):425-33.
  • 12. Kasai N, Sakamoto A. New subgrouping of small thyroid carcinomas. Cancer 1987;60(8):1767-70.
  • 13. Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: Study of 299 cases. J Clin Endocrinol Metab 2004;89(8):3713-20.
  • 14. Chow SM, Law SC, Mendenhall WM, et al. Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):784-95.
  • 15. Lee J, Rhee Y, Lee S, et al. Frequent, aggressive behaviors of thyroid microcarcinomas in korean patients. Endocr J 2006;53(5):627-32.
  • 16. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer 2003;98(1):31-40.
  • 17. Shaha AR, Shah JP, Loree TR. Differentiated thyroid cancer presenting initially with distant metastasis. Am J Surg 1997;174(5):474-6.
Ege Tıp Dergisi-Cover
  • ISSN: 1016-9113
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1962
  • Yayıncı: Ersin HACIOĞLU
Sayıdaki Diğer Makaleler

Çocuklarda demir eksikliği anemisinin tiroid hormonları üzerine etkisi

Zahide YALAKİ, Esra YAZARLI, Bülent ALİOĞLU

Hücre içi trafik ve hücre davranış özellikleri

BERRİN ÖZDİL BAY, HÜSEYİN AKTUĞ, ÇEVİK GÜREL, KUBİLAY DOĞAN KILIÇ, Gökçe Ceren KUŞÇU, Yasemin ADALI

Multi dedektör bilgisayarlı tomografi ile karotid arter plaklarında kontrastlanma miktarlarının saptanması

HALİL İBRAHİM ÖZDEMİR, Celal ÇINAR, Halil BOZKAYA, AYŞE GÜLER, İsmail ORAN

Kraniyal görüntüleme bulguları ile akçaağaç şurubu idrar hastalığı

Yusuf KALE, Ece KARAOĞLU

Tek doz duloksetin genç erkek hastada hiponatremiye neden olabilir mi?

Tanzer KORKMAZ, FUNDA KARBEK AKARCA, Selen ÇOME, Cem ERTAN

Bariatrik cerrahi ile ilgili ilk sonuçlarımız

TURGUT ANUK, Neşet KÖKSAL, Fatih AVŞAR, TÜLAY DİKEN ALLAHVERDİ, BARLAS SULU, HÜLYA ÇAKMUR

Deneysel diabet modeli oluşturulan farelerde tirozin kinaz inhibitör uygulanımının testis dokusu üzerine olan etkilerinin pluripotensi kapasitesi ve hücre adezyonu özelinde araştırılması

Kaan ÖZDEDELİ, HÜSEYİN AKTUĞ, Fatih OLTULU, GÜLPERİ ÖKTEM, ALTUĞ YAVAŞOĞLU, EDA AÇIKGÖZ, GÜRKAN YİĞİTTÜRK, Kenan DEMİR, AYŞEGÜL UYSAL

Çocukluk çağı miyastenia gravis

İhsan ÇAKIR, Gamze Öztürk KARABULUT, Birsen GÖKYİĞİT, Ebru Demet AYGIT, Osman Bulut OCAK, Aslı İNAL

Homozigot ailevi hiperkolesterolemi olgusunda uzun dönem izlem: LDL aferezi ve tedavide yaşanan sorunlar

Levent CAN, Meral KAYIKÇIOĞLU, Selen BAYRAKTAR, Mahmut ÇOKER

Tiroglossal duktus kistinde gelişen papiller tiroid karsinom

Aykut BOZAN, Ayşe POLAT, Hayrettin Cengiz ALPAY, SERCAN GÖDE